Literature DB >> 1970136

Concomitant depression of locus coeruleus neurons and of flexor reflexes by an alpha 2-adrenergic agonist in rats: a possible mechanism for an alpha 2-mediated muscle relaxation.

A Palmeri1, M Wiesendanger.   

Abstract

The alpha 2-agonist tizanidine, clinically used as an antispastic drug, also strongly reduces polysynaptic flexor reflexes. The hypothesis was tested that the noradrenergic coerulespinal system exerts a tonic facilitation on spinal reflexes and that the depressant effects of tizanidine may be explained by an alpha 2-mediated autoinhibition of the tonic activity of locus coeruleus neurons, resulting in a disfacilitation of the spinal reflexes. The following results support this working hypothesis: (1) systemic injections of tizanidine markedly decreased the spontaneous activity of locus coeruleus neurons, but not of non-locus coeruleus neurons. The alpha 2-antagonist yohimbine reversed this effect. (2) The time course of diminished locus coeruleus activity paralleled that of depressed flexor reflexes. (3) Flexor reflexes were also markedly depressed by the alpha 1-adrenergic antagonist prazosin, administered alone, which is in line with the proposition that the noradrenergic system exerts a tonic facilitation on spinal neurons by way of alpha 1-adrenergic receptor activation. (4) Flexor reflexes were facilitated by conditioning microstimulation of locus coeruleus neurons, and this effect was reversed by prazosin. (5) Flexor reflexes significantly diminished in size following placement of an irreversible lesion in the ipsilateral locus coeruleus. Although these results strongly support the above hypothesis regarding a descending modulatory function of the descending locus coeruleus system on spinal reflexes, possible additional mechanisms, perhaps also involving the ascending projection of the locus coeruleus to supraspinal motor structures, remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970136     DOI: 10.1016/0306-4522(90)90311-q

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury.

Authors:  Alexander G Rabchevsky; Patrick H Kitzman
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

2.  Antispastic effects of L-dopa.

Authors:  J Eriksson; B Olausson; E Jankowska
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

Review 3.  Pharmacological interventions other than botulinum toxin for spasticity after stroke.

Authors:  Cameron Lindsay; Aphrodite Kouzouna; Christopher Simcox; Anand D Pandyan
Journal:  Cochrane Database Syst Rev       Date:  2016-10-06

Review 4.  Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.

Authors:  A J Wagstaff; H M Bryson
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

5.  Modulation of the transmission in group II heteronymous pathways by tizanidine in spastic hemiplegic patients.

Authors:  E Maupas; P Marque; C F Roques; M Simonetta-Moreau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

6.  An analysis of adrenergic influences on the sural-gastrocnemius reflex of the decerebrated rabbit.

Authors:  J Harris; R W Clarke
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

7.  Locus coeruleus neurons: cessation of activity during cataplexy.

Authors:  M F Wu; S A Gulyani; E Yau; E Mignot; B Phan; J M Siegel
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

8.  Influence of Addition of Dexmedetomidine or Fentanyl to Bupivacaine Lumber Spinal Subarachnoid Anesthesia for Inguinal Hernioplasty.

Authors:  Ayman Eskander T Saadalla; Osama Yehia A Khalifa
Journal:  Anesth Essays Res       Date:  2017 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.